INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,041 | -12.9% | 30,953 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,821 | -45.5% | 30,953 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $25,381 | -47.4% | 30,953 | 0.0% | 0.00% | -57.1% |
| Q4 2022 | $48,287 | -8.9% | 30,953 | 0.0% | 0.01% | -22.2% |
| Q3 2022 | $53,000 | -1.9% | 30,953 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $54,000 | -51.4% | 30,953 | 0.0% | 0.01% | -46.7% |
| Q1 2022 | $111,000 | -27.0% | 30,953 | +1.3% | 0.02% | -25.0% |
| Q4 2021 | $152,000 | -30.9% | 30,548 | -1.0% | 0.02% | -33.3% |
| Q3 2021 | $220,000 | -23.1% | 30,842 | 0.0% | 0.03% | -23.1% |
| Q2 2021 | $286,000 | +1.4% | 30,842 | +1.4% | 0.04% | -7.1% |
| Q1 2021 | $282,000 | +9.7% | 30,402 | +4.6% | 0.04% | -4.5% |
| Q4 2020 | $257,000 | – | 29,076 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |